Levaquin: Potent Antibiotic for Serious Bacterial Infections
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.46 | $43.86 (0%) | 🛒 Add to cart |
| 60 | $1.29 | $87.72 $77.40 (12%) | 🛒 Add to cart |
| 90 | $1.12 | $131.58 $100.62 (24%) | 🛒 Add to cart |
| 120 | $0.99 | $175.44 $118.68 (32%) | 🛒 Add to cart |
| 180 | $0.86 | $263.16 $154.80 (41%) | 🛒 Add to cart |
| 270 | $0.77 | $394.74 $208.98 (47%) | 🛒 Add to cart |
| 360 | $0.75
Best per pill | $526.32 $269.18 (49%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $1.72 | $34.40 (0%) | 🛒 Add to cart |
| 30 | $1.63 | $51.60 $49.02 (5%) | 🛒 Add to cart |
| 60 | $1.55 | $103.20 $92.88 (10%) | 🛒 Add to cart |
| 90 | $1.41 | $154.80 $127.28 (18%) | 🛒 Add to cart |
| 120 | $1.29 | $206.40 $154.80 (25%) | 🛒 Add to cart |
| 180 | $1.07 | $309.60 $193.50 (38%) | 🛒 Add to cart |
| 270 | $0.97 | $464.40 $262.30 (44%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $619.20 $318.20 (49%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $1.89 | $37.84 (0%) | 🛒 Add to cart |
| 30 | $1.72 | $56.76 $51.60 (9%) | 🛒 Add to cart |
| 60 | $1.63 | $113.52 $98.04 (14%) | 🛒 Add to cart |
| 90 | $1.46 | $170.28 $131.58 (23%) | 🛒 Add to cart |
| 120 | $1.38 | $227.04 $165.12 (27%) | 🛒 Add to cart |
| 180 | $1.20 | $340.56 $216.72 (36%) | 🛒 Add to cart |
| 270 | $1.13 | $510.84 $306.16 (40%) | 🛒 Add to cart |
| 360 | $1.03
Best per pill | $681.12 $371.52 (45%) | 🛒 Add to cart |
Synonyms
| |||
Levaquin (levofloxacin) is a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of adults with serious bacterial infections. As a synthetic chemotherapeutic agent, it demonstrates bactericidal activity through inhibition of bacterial DNA gyrase and topoisomerase IV enzymes. This medication is reserved for cases where first-line antibiotics have failed or are inappropriate due to resistance patterns or patient factors. Levaquin represents an important therapeutic option in the antimicrobial arsenal for qualified healthcare providers managing complex infections.
Features
- Contains levofloxacin, the L-isomer of ofloxacin with enhanced antibacterial activity
- Available in oral tablets (250mg, 500mg, 750mg) and intravenous solution
- Broad-spectrum coverage against Gram-positive, Gram-negative, and atypical pathogens
- Once-daily dosing regimen for improved patient compliance
- Excellent tissue penetration including prostate, lung, and skin structure concentrations
Benefits
- Effective against multidrug-resistant pathogens including Pseudomonas aeruginosa
- Rapid bactericidal action reduces bacterial load quickly
- Comprehensive coverage eliminates polymicrobial infections
- Convenient dosing schedule supports outpatient treatment
- Proven efficacy in complicated urinary tract and respiratory infections
- Reduces risk of infection progression to sepsis or tissue necrosis
Common use
Levaquin is prescribed for complicated urinary tract infections, acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, skin and skin structure infections, and chronic bacterial prostatitis. It is also indicated for inhalational anthrax exposure and plague. Healthcare providers reserve Levaquin for situations where alternative antibiotics are not suitable due to resistance patterns, allergy concerns, or treatment failure.
Dosage and direction
The recommended dosage varies by infection type and severity. For most indications: 250-750mg orally or intravenously once every 24 hours. Duration typically ranges from 7-14 days depending on clinical response. Administer tablets with water, with or without food. Maintain adequate hydration during treatment. Complete the full course even if symptoms improve earlier. Dosage adjustment required for renal impairment (CrCl <50 mL/min).
Precautions
Monitor patients for tendon pain, swelling, or inflammation; discontinue immediately if tendinitis suspected. Avoid excessive sunlight exposure due to photosensitivity risk. Use caution in patients with CNS disorders (e.g., epilepsy) due to potential seizure threshold reduction. Monitor blood glucose levels in diabetic patients. Assess psychiatric status regularly as mood alterations may occur. Not recommended for pediatric patients except for inhalational anthrax.
Contraindications
Hypersensitivity to levofloxacin, other quinolones, or product components. Contraindicated in patients with history of tendon disorders related to fluoroquinolone use. Avoid concurrent administration with tizanidine. Not recommended in patients with known QTc prolongation, uncorrected hypokalemia, or taking Class IA or III antiarrhythmic agents.
Possible side effect
Common: nausea (1.2%), diarrhea (1.1%), headache (0.9%), constipation (0.8%). Serious: tendon rupture, peripheral neuropathy, CNS effects (dizziness, insomnia, seizures), QT prolongation, hypoglycemia, hepatic toxicity, photosensitivity, Clostridium difficile-associated diarrhea. Discontinue immediately at first sign of tendon pain, neurological symptoms, or serious hypersensitivity reaction.
Drug interaction
Significant interactions with: antacids containing magnesium/aluminum, sucralfate, metal cations (reduced absorption—separate by 2 hours before or 4 hours after). Enhanced QTc prolongation with antiarrhythmics, antipsychotics, antidepressants. Increased risk of hypoglycemia with sulfonylureas. Enhanced CNS stimulation with NSAIDs. Reduced seizure threshold with theophylline. Monitor warfarin patients closely for increased anticoagulant effect.
Missed dose
Take the missed dose as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing intervals to ensure consistent antibiotic levels. Contact healthcare provider if multiple doses missed or uncertainty about dosing schedule.
Overdose
Symptoms may include CNS excitation (seizures, confusion, dizziness), gastrointestinal distress, and prolongation of QT interval. Management is supportive with ECG monitoring for QT effects. Hemodialysis removes approximately 10% of dose. Maintain hydration and electrolyte balance. No specific antidote exists. Contact poison control center for latest management recommendations.
Storage
Store tablets at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). Keep in original container, tightly closed. Protect from light and moisture. Do not store in bathroom or damp areas. Keep out of reach of children and pets. Do not use after expiration date. IV solution: store at room temperature; protect from freezing and light.
Disclaimer
This information describes Levaquin but does not replace professional medical advice. Consult healthcare provider for diagnosis and treatment decisions. Use only as prescribed. Report any adverse reactions to FDA MedWatch. Antibiotic resistance may develop with inappropriate use. Complete full course as directed unless experiencing serious side effects.
Reviews
Clinical trials demonstrate Levaquin’s efficacy: 93% clinical cure rate in complicated UTI studies, 92% success in respiratory infections. Post-marketing surveillance shows effectiveness in real-world settings but notes side effect profile limitations. Healthcare providers value its spectrum but reserve use due to safety considerations. Patient satisfaction varies with infection resolution balanced against potential adverse effects. Most reviews emphasize appropriate patient selection and monitoring.